Author

Jennifer Mackie

Observed names: J Mackie, J. Mackie, Mackie, Jennifer

Observed institutions: University of Leicester, Royal Papworth Hospital, Dumfries and Galloway Royal Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, NHS Dumfries and Galloway, University Hospitals of Leicester NHS Trust, University Hospital Southampton NHS Foundation Trust, National Institute for Health and Care Research, Papworth Hospital NHS Foundation Trust, NIHR Newcastle Biomedical Research Centre, Princess Alexandra Hospital, NIHR Leicester Biomedical Research Centre, University of Southampton, Imperial College London, Newcastle University

OpenAlex ID: A5086203885

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

2022 · R A Evans, O C Leavy, et al. · The Lancet Respiratory Medicine · 413

PDF

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 224

PDF

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 121

A second update on mapping the human genetic architecture of COVID-19

2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 118

PDF

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

2024 · Felicity Liew, Claudia Efstathiou, et al. · Nature Immunology · 107

PDF

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

2023 · Betty Raman, Celeste McCracken, et al. · The Lancet Respiratory Medicine · 57

PDF

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

PDF

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

PDF

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

2023 · Callum Jackson, Iain D Stewart, et al. · The Lancet Respiratory Medicine · 35

Accelerated immune ageing is associated with COVID-19 disease severity

2024 · Janet M. Lord, Tonny Veenith, et al. · Immunity & Ageing · 34

PDF

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

2023 · Bang Zheng, Giulia Vivaldi, et al. · The Lancet Regional Health - Europe · 29

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

2023 · Hamish J.C. McAuley, Rachael A. Evans, et al. · EClinicalMedicine · 24

PDF

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

2023 · Omer Elneima, Hamish J C McAuley, et al. · International Journal of Epidemiology · 23

PDF

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

2023 · Maxime Taquet, Zuzanna Skorniewska, et al. · Brain Communications · 14

PDF

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

PDF

Mid-term follow-up after aortic valve replacement with the Carpentier Edwards Magna Ease prosthesis

2020 · Taufiek K. Rajab, Jason M. Ali, et al. · Journal of Cardiothoracic Surgery · 12

PDF

Long COVID research: an update from the PHOSP-COVID Scientific Summit

2023 · Christopher E Brightling, Rachael A Evans, et al. · The Lancet Respiratory Medicine · 11

PDF

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 9

PDF

High-Flow Nasal Oxygen Therapy After Cardiac Surgery

2026 · Edward Litton, Rachael L. Parke, et al. · JAMA Network Open · 6

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

#2866 The CompAct-HD trial reports a persistent inflammatory profile in patients undergoing haemodialysis, acutely exacerbated with each treatment

2024 · Duha Ilyas, Elizabeth Blackburn, et al. · Nephrology Dialysis Transplantation · 1

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

PDF

The CompAct-HD Trial Reports an Acute Complement Activity-Associated Inflammatory Response Within 15 Minutes of Starting Hemodialysis

2023 · Andy Herbert, Duha Ilyas, et al. · Journal of the American Society of Nephrology

Works count: 26

Citation count: 1,787

H-index: 15

I10-index: 19